SG Americas Securities’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
SG Americas Securities's MXCT Position: Q1 2026 in Review
SG Americas Securities sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 49,402 shares — an estimated $77K sold.
SG Americas Securities first reported a position in MXCT in Q3 2021 and held it in 16 quarters. The position peaked at $228K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- SG Americas Securities reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
- SG Americas Securities sold 49,402 MaxCyte shares in Q1 2026, an estimated $77K.
- SG Americas Securities first reported a position in MaxCyte in Q3 2021 and held it in 16 quarters.
- SG Americas Securities's MaxCyte position peaked at $228K in Q4 2023.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.